UnitedHealth Group Inc (NYSE:UNH) Receives $283.84 Consensus PT from Brokerages

Shares of UnitedHealth Group Inc (NYSE:UNH) have received a consensus recommendation of “Buy” from the twenty-one analysts that are presently covering the stock, MarketBeat.com reports. Five investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating on the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $285.68.

A number of analysts have weighed in on UNH shares. SunTrust Banks reaffirmed a “buy” rating and set a $335.00 price objective (up from $310.00) on shares of UnitedHealth Group in a research report on Monday. Zacks Investment Research raised UnitedHealth Group from a “sell” rating to a “buy” rating and set a $269.00 price objective for the company in a research report on Monday, July 22nd. UBS Group decreased their price objective on UnitedHealth Group from $281.00 to $257.00 and set a “neutral” rating for the company in a research report on Thursday, October 17th. Credit Suisse Group set a $293.00 price objective on UnitedHealth Group and gave the stock a “buy” rating in a research report on Thursday, August 29th. Finally, ValuEngine raised UnitedHealth Group from a “sell” rating to a “hold” rating in a research report on Wednesday, October 2nd.

UnitedHealth Group stock traded up $1.30 during mid-day trading on Thursday, reaching $274.23. 3,726,308 shares of the company were exchanged, compared to its average volume of 4,538,164. UnitedHealth Group has a twelve month low of $208.07 and a twelve month high of $287.94. The firm’s 50-day simple moving average is $242.64 and its two-hundred day simple moving average is $242.60. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.70 and a current ratio of 0.70. The firm has a market cap of $255.23 billion, a PE ratio of 21.29, a price-to-earnings-growth ratio of 1.43 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $3.88 earnings per share for the quarter, topping analysts’ consensus estimates of $3.75 by $0.13. UnitedHealth Group had a return on equity of 25.30% and a net margin of 5.57%. The company had revenue of $60.35 billion during the quarter, compared to analysts’ expectations of $59.84 billion. During the same period last year, the firm earned $3.41 EPS. The firm’s revenue for the quarter was up 6.7% on a year-over-year basis. As a group, equities research analysts anticipate that UnitedHealth Group will post 14.96 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a $1.08 dividend. This represents a $4.32 annualized dividend and a dividend yield of 1.58%. UnitedHealth Group’s dividend payout ratio is currently 33.54%.

In other news, Director Richard T. Burke sold 2,500 shares of the firm’s stock in a transaction that occurred on Tuesday, September 17th. The stock was sold at an average price of $232.76, for a total value of $581,900.00. Following the completion of the sale, the director now directly owns 187,979 shares of the company’s stock, valued at approximately $43,753,992.04. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Timothy Patrick Flynn purchased 2,000 shares of UnitedHealth Group stock in a transaction dated Wednesday, August 28th. The stock was acquired at an average cost of $227.55 per share, with a total value of $455,100.00. Following the completion of the acquisition, the director now directly owns 5,524 shares in the company, valued at $1,256,986.20. The disclosure for this purchase can be found here. Insiders sold a total of 33,177 shares of company stock valued at $7,842,582 over the last three months. Insiders own 0.82% of the company’s stock.

Institutional investors and hedge funds have recently bought and sold shares of the company. Eastern Bank increased its position in UnitedHealth Group by 2.0% during the second quarter. Eastern Bank now owns 69,088 shares of the healthcare conglomerate’s stock worth $16,858,000 after buying an additional 1,375 shares in the last quarter. Capital Investment Advisors LLC grew its position in shares of UnitedHealth Group by 26.2% in the second quarter. Capital Investment Advisors LLC now owns 6,379 shares of the healthcare conglomerate’s stock valued at $1,556,000 after purchasing an additional 1,323 shares during the period. Berkeley Capital Partners LLC grew its position in shares of UnitedHealth Group by 7.4% in the second quarter. Berkeley Capital Partners LLC now owns 2,220 shares of the healthcare conglomerate’s stock valued at $542,000 after purchasing an additional 153 shares during the period. Calton & Associates Inc. grew its position in shares of UnitedHealth Group by 22.7% in the second quarter. Calton & Associates Inc. now owns 2,074 shares of the healthcare conglomerate’s stock valued at $506,000 after purchasing an additional 384 shares during the period. Finally, Granite Investment Partners LLC grew its position in shares of UnitedHealth Group by 1.8% in the second quarter. Granite Investment Partners LLC now owns 67,540 shares of the healthcare conglomerate’s stock valued at $16,480,000 after purchasing an additional 1,193 shares during the period. 85.88% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Article: Understanding Options Trading

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.